台湾早产儿视网膜病变治疗的十年流行病学
该回顾性横断面研究纳入2002至2011年台湾11180例住院超过28天且存活出院的早产儿,分析首次接受早产儿视网膜病变(ROP)治疗的发生率。4096例ROP患者中6.5%(265例)接受治疗,激光最常见(199例),其次为玻璃体腔抗血管内皮生长因子(VEGF)注射(38例)。研究期间需治疗ROP发生率上升,抗VEGF注射使用增加,2010年后治疗模式由激光转向抗VEGF注射。
要点
- 4096例ROP患者中6.5%(265例)接受治疗,激光199例最常见。
- 研究期间需治疗ROP发生率上升,玻璃体腔抗VEGF注射使用增加。
- 2003年后由冷冻和巩膜扣带/玻璃体切割转向激光,2010年后由激光转向抗VEGF注射。
核心结论
- 2002至2011年台湾因ROP接受玻璃体腔抗VEGF注射的比例增加,2011年激光治疗使用少于玻璃体腔抗VEGF注射。
研究设计与样本
- 回顾性横断面研究纳入2002至2011年台湾11180例住院时间超过28天且住院期间存活的早产儿。
主要发现
- 4096例ROP患者中6.5%(265例)接受治疗。
- 治疗方式中激光199例,玻璃体腔抗VEGF注射38例,巩膜扣带或平坦部玻璃体切割14例,冷冻治疗14例。
- 研究期间需治疗ROP的发生率上升,玻璃体腔抗VEGF注射的使用增加。
- 观察到2003年后治疗方式由冷冻治疗和巩膜扣带/平坦部玻璃体切割转向激光治疗,2010年后由激光治疗转向玻璃体腔抗VEGF注射。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To understand the epidemiology of retinopathy of prematurity (ROP) requiring treatment in Taiwan from 2002 to 2011. METHODS: This retrospective cross-sectional study enrolled 11,180 premature patients with a length of stay >28 days who survived during hospitalization. The incidence of the first ROP treatment was analyzed. RESULTS: Among ROP patients (n = 4,096), 6.5% (n = 265) received treatment. The most frequently performed treatment was laser administration (n = 199), followed by intravitreal anti-vascular endothelial growth factor (VEGF) injection (n = 38), scleral buckle or pars plana vitrectomy (n = 14), and cryotherapy (n = 14). The incidence of ROP requiring treatment increased during the study period, as did the use of intravitreal anti-VEGF injection. Shifts in the treatment modality from cryotherapy and scleral buckle/pars plana vitrectomy to laser treatment after 2003 and from laser treatment to intravitreal anti-VEGF injection after 2010 were observed. CONCLUSION: In Taiwan, the incidence of the use of intravitreal anti-VEGF injection for treating ROP increased between 2002 and 2011. Laser treatment was less frequently used than intravitreal anti-VEGF injection in 2011.
引用
- Kang EY, Hsu KH, Chu SM, et al. TEN-YEAR EPIDEMIOLOGY OF RETINOPATHY OF PREMATURITY TREATMENT IN TAIWAN. Retina. 2020. PMID: 31764611. doi:10.1097/IAE.0000000000002684
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。